Increasing genomic and epigenomic complexity in the clonal evolution from in situ to manifest t (14; 18)-positive follicular lymphoma

J Schmidt, I Salaverria, A Haake, I Bonzheim, P Adam… - Leukemia, 2014 - nature.com
J Schmidt, I Salaverria, A Haake, I Bonzheim, P Adam, S Montes-Moreno, MA Piris, F Fend…
Leukemia, 2014nature.com
Follicular lymphoma (FL) is characterized besides the t (14; 18)(q32; q21), by recurrent
chromosomal alterations and somatic mutations. In this study, we analyzed cases of FL in
situ (FLIS) without manifest FL (mFL), partial involvement by FL (PFL) and paired cases of
FLIS and mFL to detect possible early chromosomal imbalances, mutations, as well as DNA-
methylation patterns of genomic regions of selected genes. We demonstrate that all paired
FLIS and mFL cases were clonally related, based on IGH rearrangement patterns and BCL2 …
Abstract
Follicular lymphoma (FL) is characterized besides the t (14; 18)(q32; q21), by recurrent chromosomal alterations and somatic mutations. In this study, we analyzed cases of FL in situ (FLIS) without manifest FL (mFL), partial involvement by FL (PFL) and paired cases of FLIS and mFL to detect possible early chromosomal imbalances, mutations, as well as DNA-methylation patterns of genomic regions of selected genes. We demonstrate that all paired FLIS and mFL cases were clonally related, based on IGH rearrangement patterns and BCL2 breakpoint sequences. FLIS and PFL had no or few secondary chromosomal imbalances detectable by array comparative genomic hybridization (FLIS 0.8 copy number alterations (CNA)/case; PFL 2.0 CNA/case; mFL 6.3 CNA/case) and a lower level of DNA methylation of genes recurrently de novo methylated in lymphomas, as compared with mFL. EZH2 Tyr641 mutations were detected in a subset of both FLIS (2/9) and PFL (1/3) cases. In conclusion, these findings provide evidence that FLIS represents a FL precursor lesion of long-lived clonal B cells carrying the t (14; 18) with no or few secondary genetic changes. Our data suggest that there may be more than one distinct lesion driving the progression from FLIS to manifest lymphoma.
nature.com